PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

OHSU research highlights promising strategy to help vaccines outsmart HIV

Researchers believe they have discovered a method to help make an HIV vaccine effective prior to, and perhaps after, infection

2013-05-24
(Press-News.org) PORTAND, Ore. – A new discovery at Oregon Health & Science University highlights an ingenious method to ensure the body effectively reacts when infected with the highly evasive HIV virus that causes AIDS. The same team of researchers has been utilizing this unique approach to develop its own HIV vaccine candidate, which has so far shown promising results in animal studies. This latest research finding will be published in the May 24, 2013, edition of the journal Science.

"A major challenge in developing an effective HIV vaccine is figuring out how to target this evasive virus," said Dr. Louis Picker, M.D., associate director of the OHSU Vaccine and Gene Therapy Institute, where the work was conducted.

CD8+ "cytotoxic" T cells are an important component of the immune system and are particularly important for pathogens, like HIV, that easily evade antibodies. They serve as sentries within the body that detect and destroy virus-infected cells, accomplishing this function by recognizing short viral peptides on the surface of infected cells. T-cells are designed to be quite frugal in the number of different viral peptides they recognize, typically responding to just a handful of such peptides. This is a problem for control of HIV, which is able to able change its peptides and thus escape T cells responses that do not target the relatively few functionally critical peptides that can't change without debilitating the virus. In the vast majority of HIV infections, the few viral peptides recognized by T cells are not the vulnerable ones, and the virus escapes.

Therefore, the strategy that Dr. Picker and his colleagues adopted was to try to develop a vaccine to increase the number of viral peptides that T cells would recognize, reasoning that increasing this "recognition breadth" would allow T cells to more effectively respond to HIV.

The researchers found that cytomegalovirus or CMV, a common virus already carried by a large percentage of the population, may hold the key. Their studies in the non-human primate model of HIV, called SIV, found that a modified version of CMV engineered to express SIV proteins generates SIV-specific T cells that recognize three-fold as many SIV peptides as T cell generated by conventional vaccines and SIV itself. Moreover, these responses were entirely different from conventional responses, such that even viruses that had previously escaped natural responses would still be vulnerable. In effect, the hunters of the body were provided with a much better targeting system to help them find and destroy an elusive enemy.

Picker and his colleagues believe an HIV vaccine equipped with a modified CMV vector might be able to both prevent infection (prophylactic vaccine) and effectively battle the virus even if applied post-infection in individuals with infections suppressed by anti-retroviral therapy. Moving forward, the research team hopes to utilize this new information to create customized CMV vectors with a broad ability to identify several components of HIV and then incorporate this component into an effective vaccine.

"We hope we can begin clinical trials in human patients within a few years," explained Dr. Picker. "This new information gives us a much clearer roadmap for effectively targeting the disease which to this point has found ways to evade the human immune system."

### National Institutes of Health (P01 AI094417, RO1 AI060392, RO1 AI059457, P51 OD 011092 and contract #HHSN261200800001E), the Bill & Melinda Gates Foundation and the International AIDS Vaccine Initiative funded this research.

OHSU and paper authors Drs. Picker, Hansen, Früh and Nelson have a significant financial interest in TomegaVax, Inc., a company that may have a commercial interest in the results of this research and technology. The potential individual and institutional conflicts of interest have been reviewed and managed by OHSU.

About OHSU Oregon Health & Science University is the state's only academic health and research university. As Portland's largest employer with approximately 14,000 employees, OHSU's size contributes to its ability to provide many services and community support not found anywhere else in the state. OHSU serves patients from every corner of Oregon and is a conduit for learning for more than 4,300 students and trainees. OHSU is the source of more than 200 community outreach programs that bring health and education services to each county in the state.


ELSE PRESS RELEASES FROM THIS DATE:

Hormone levels may provide key to understanding psychological disorders in women

2013-05-24
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL. The results suggest a monthly window of opportunity that could potentially be targeted in efforts to prevent common mental health problems developing in women. The research is the first to show a potential link between psychological vulnerability and the timing of a biological cycle, in this case ovulation. A common symptom of mood and anxiety problems is the tendency to experience ...

Heart healthy lifestyle may cut kidney disease patients' risk of kidney failure

2013-05-24
Washington, DC (May 23, 2013) — Maintaining a heart healthy lifestyle may also help protect chronic kidney disease patients from developing kidney failure and dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings suggest that patients with kidney disease should be encouraged to improve their heart health. Poor kidney health puts people at risk of developing heart problems, but it's unclear whether the opposite is true. Does heart health also affect kidney health? To investigate, ...

Multiple research teams unable to confirm high-profile Alzheimer's study

2013-05-24
Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science. Those results, presented online Feb. 9, 2012, suggested that the drug bexarotene (marketed as Targretin®) could rapidly reverse the buildup of beta amyloid plaques (Aβ) — a pathological hallmark of Alzheimer's disease — in the brains of mice. According to the authors of the 2012 report, drug treatment quickly removed most of the plaques and brought rapid reversal ...

Antibiotics: A new understanding of sulfonamide nervous system side effects

2013-05-24
Since the discovery of Prontosil in 1932, sulfonamide antibiotics have been used to combat a wide spectrum of bacterial infections, from acne to chlamydia and pneumonia. However, their side effects can include serious neurological problems like nausea, headache, dizziness, hallucinations and even psychosis. In a recent Science publication, EPFL researchers have shown for the first time how sulfonamides can interfere with a patient's nervous system. The problem is that, even though we know how sulfonamides work, we do not understand the actual molecular mechanics behind ...

NIH scientists discover molecule triggers sensation of itch

2013-05-24
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as the sensation of itch. The small molecule, called natriuretic polypeptide b (Nppb), streams ahead and selectively plugs into a specific nerve cell in the spinal cord, which sends the signal onward through the central nervous system. When Nppb or its nerve cell was removed, mice stopped scratching at a broad array of itch-inducing substances. The signal wasn't going ...

Bittersweet: Bait-averse cockroaches shudder at sugar

2013-05-24
VIDEO: This movie shows the preferences of wild type and glucose-averse cockroaches for off-the-shelf store-bought foods with and without glucose. Click here for more information. Sugar isn't always sweet to German cockroaches, especially to the ones that avoid roach baits. In a study published May 24 in the journal Science, North Carolina State University entomologists show the neural mechanism behind the aversion to glucose, the simple sugar that is a popular ingredient ...

Astronomers team up with the public to solve decade old puzzle

2013-05-24
An extremely precise measurement of the distance to a star system has finally allowed astronomers to solve a decade-old puzzle, confirming understanding of the way exotic objects like black holes interact with nearby stars. Published today in prestigious journal Science, a team of astronomers headed by Dr James Miller-Jones from the Curtin University node of the International Centre for Radio Astronomy Research (ICRAR), have measured the distance to star system SS Cygni to be 372 light years, much closer than a previous measurement made by the Hubble Space Telescope in ...

Economic incentives increase blood donation without negative consequences

2013-05-24
Can economic incentives such as gift cards, T-shirts, and time off from work motivate members of the public to increase their donations of blood? A team of researchers including Johns Hopkins Carey Business School Assistant Professor Mario Macis says the answer is an emphatic yes. Pointing to a large body of recent research that supports their argument, the three economists write in the May 24, 2013, issue of Science that the World Health Organization and national blood collection agencies should reconsider their opposition to economic incentives for much-needed blood ...

Accurate distance measurement resolves major astronomical mystery

2013-05-24
Sometimes astronomy is like real estate -- what's important is location, location, and location. Astronomers have resolved a major problem in their understanding of a class of stars that undergo regular outbursts by accurately measuring the distance to a famous example of the type. The researchers used the National Science Foundation's Very Long Baseline Array (VLBA) and the European VLBI Network (EVN) to precisely locate one of the most-observed variable-star systems in the sky -- a double-star system called SS Cygni -- at 370 light-years from Earth. This new distance ...

Drug reverses Alzheimer's disease deficits in mice, Pitt research confirms

2013-05-24
An anti-cancer drug reverses memory deficits in an Alzheimer's disease mouse model, University of Pittsburgh Graduate School of Public Health researchers confirm in the journal Science. The research, funded by the National Institutes of Health's National Institute on Aging and Alzheimer's Association, reviewed previously published findings on the drug bexarotene, approved by the U.S. Food and Drug Administration for use in cutaneous T cell lymphoma. The Pitt Public Health researchers were able to verify that the drug does significantly improve cognitive deficits in mice ...

LAST 30 PRESS RELEASES:

Sulfated yeast rises to the challenge facing rare earth metals

Global analysis reveals how biochar supercharges composting and cuts greenhouse gases

Blocking a cellular switch could prevent lung-scarring disease

Planet formation depends on when it happens: UNLV model shows why

Deep sleep supports memory via brain fluid and neural rhythms

Biochar and iron additives show promise for reviving degraded peatlands and locking away carbon

Cancer cells reactivate embryo-like gene editors to fuel growth

AI analysis of world’s largest heart attack datasets opens way to new treatment strategies

Decoding dangers of Arctic sea ice with seismic, radar method

Counting bites with AI might one day help prevent childhood obesity

Utah chemists discover enzyme that could help build next-generation GLP-1 drugs

Surprising bacteria discovery links Hawaiʻi’s groundwater to the ocean

New grants for schools offer CPR training and resources to make campuses safer

30 NFL players urge fans to join Nation of Lifesavers, learn lifesaving CPR

Study finds humans outweigh climate in depleting Arizona's water supply

Old-school material could power quantum computing, cut data center energy use

Vanderbilt scientist tackles key roadblock for AI in drug discovery

Overheating bat boxes place bats in mortal danger during heatwaves

Study shows medical-legal partnerships aid recovery for patients with violent injuries

Learning the language of lasso peptides to improve peptide engineering

Social conflict among strongest predictors of teen mental health concerns

New framework can improve the planning stage of surgical quality improvement projects

Research shows anger, not fear, shifts political beliefs

Gale and Ira Drukier Prize in Children’s Health Research awarded to pediatric rheumatologist at Boston Children’s Hospital

UNF chemistry professor awarded NSF Grant to advance laser-based measurement technology

Research shows how Dust Bowl-type drought causes unprecedented productivity loss

Non-hibernating pikas' protein restriction tweaks their gut microbiome to help them survive the winter, when winter-active herbivores often struggle to find dietary protein

Not for hearing but for symbiosis

Disconnected cerebral hemisphere in epilepsy patients shows sleep-like state during wakefulness

Incentivizing risk to inspire investments in clean innovation for aviation

[Press-News.org] OHSU research highlights promising strategy to help vaccines outsmart HIV
Researchers believe they have discovered a method to help make an HIV vaccine effective prior to, and perhaps after, infection